We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

173 hedge funds and large institutions have $834M invested in Cardiovascular Systems, Inc. in 2022 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 65 increasing their positions, 57 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 24

20% more capital invested

Capital invested by funds: $693M → $834M (+$141M)

14% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 57

4% more funds holding

Funds holding: 167173 (+6)

Holders
173
Holders Change
+6
Holders Change %
+3.59%
% of All Funds
2.73%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
31
Increased
65
Reduced
57
Closed
24
Calls
$1.75M
Puts
Net Calls
+$1.75M
Net Calls Change
+$1.28M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$160M +$1.56M +80,138 +1%
BCM
2
Brown Capital Management
Maryland
$131M +$10.2K +528 +0%
CIP
3
Champlain Investment Partners
Vermont
$78.8M -$44.4K -2,290 -0.1%
Vanguard Group
4
Vanguard Group
Pennsylvania
$58.5M -$2.15M -110,546 -4%
State Street
5
State Street
Massachusetts
$38.9M -$493K -25,403 -1%
Citadel Advisors
6
Citadel Advisors
Florida
$21.9M +$7.43M +382,558 +65%
Renaissance Technologies
7
Renaissance Technologies
New York
$19.3M -$957K -49,300 -5%
Neuberger Berman Group
8
Neuberger Berman Group
New York
$18.2M +$1.27M +65,351 +9%
ACH
9
ArrowMark Colorado Holdings
Colorado
$17.1M +$853K +43,944 +6%
New York State Common Retirement Fund
10
New York State Common Retirement Fund
New York
$16.6M -$990 -51 -0%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$15.9M -$663K -34,166 -5%
Morgan Stanley
12
Morgan Stanley
New York
$13M -$1.66M -85,665 -13%
GPGA
13
Grandeur Peak Global Advisors
Utah
$12.7M -$59.1K -3,047 -0.5%
N
14
Nuveen
North Carolina
$11M +$8.04M +413,968 +333%
Millennium Management
15
Millennium Management
New York
$10.3M -$2.66M -137,290 -23%
Northern Trust
16
Northern Trust
Illinois
$10.2M -$154K -7,925 -2%
Dimensional Fund Advisors
17
Dimensional Fund Advisors
Texas
$9.15M -$548K -28,215 -7%
Assenagon Asset Management
18
Assenagon Asset Management
Luxembourg
$8.97M -$1.77M -91,165 -19%
JP Morgan Chase
19
JP Morgan Chase
New York
$8.49M -$2.49M -128,270 -25%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$8.37M +$338K +17,429 +5%
D.E. Shaw & Co
21
D.E. Shaw & Co
New York
$7.5M +$2.57M +132,349 +66%
Balyasny Asset Management
22
Balyasny Asset Management
Illinois
$7.02M +$5.15M +265,139 +583%
PPA
23
Parametric Portfolio Associates
Washington
$6.8M +$3.92M +201,847 +203%
Charles Schwab
24
Charles Schwab
California
$6.62M +$162K +8,340 +3%
DCM
25
DAFNA Capital Management
California
$6.49M

CSII Hedge Fund Activity: Q1 2022 in Review

173 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q1 2022, worth a combined $834M — up 20% from $693M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new CSII positions and 24 closed out — a net gain of 7 holders — while 65 added to existing stakes and 57 trimmed.

The largest buyer was Nuveen, adding an estimated $8.04M. The largest seller was Invesco, cutting an estimated $6.13M.

  • 173 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q1 2022, up from 167 in Q4 2021.
  • Funds reported $834M of Cardiovascular Systems, Inc. stock for Q1 2022, up 20% quarter-over-quarter.
  • 31 funds opened new Cardiovascular Systems, Inc. positions in Q1 2022 and 24 closed out, a net change of +7 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q1 2022 was Nuveen, an estimated $8.04M added.
  • The largest Cardiovascular Systems, Inc. seller in Q1 2022 was Invesco, an estimated $6.13M sold.

Based on aggregated 13F filings for Q1 2022.